• Press
  • News
  • Glossary
  • Photo gallery (in French)
  • Videos
  • Français
  • English
  • A+
  • A-

Fondation Synergie Lyon Cancer (EN)

  • The Foundation
    • Our vision, mission and values
    • History
    • Governance
    • Why Lyon ?
    • Founders and partners
    • They support us
    • Contact
  • The stakes
    • Cancer today
    • A major medical and scientific challenge
    • Advances made by research - where are we?
    • Progress of research – the experts speak
    • The path of drug discovery
  • Our research
    • Our approach
    • Our scientific orientations : tumor escape and immune surveillance
    • From science to patient : therapeutic targeting
    • Dedicated teams
  • Platforms and networks
    • Bioinformatics Center
    • Chairs of excellence
    • C3D Center
    • The tumour model laboratory
    • World Sarcoma Network
  • Support the Foundation
    • If you are a private individual
    • If you are a company
    • They support us

You are here

  • Home
  • Medicinal drug
Envoyer cet article
Print

Medicinal drug

The Public Health Code (article L.5111-1) defines a medicinal drug as a “substance or compound presented as possessing properties that can cure or prevent diseases in humans and animals, and as any substance or compound that can be used in humans and animals or that can be administered to them, in view to formulating a medical diagnosis or restoring, correcting or modifying their physiological functions through pharmacological, immunological or metabolic action”.

Drugs used to combat cancer mainly comprise cytostatics (chemotherapy) that destroy cells that divide rapidly, such as tumour cells, antihormones (hormonotherapy) which inhibit the hormones favouring certain cancers, and immunotherapy drugs that help the immune system to eliminate cancer cells. Drugs stemming from recent so-called targeted therapies combat the development of tumours, by acting specifically on certain proteins that participate in the multiplication of cancer cells and the formation of blood vessels that nourish them.

Go to glossary

Haut de page Imprimer
Fondation Synergie Lyon Cancer
Download

Download the brochure

Download the individual donation form

Download the companies donation form

Online donation form

  • The Foundation
    • Our history
    • Governance
    • Founders and partners
    • Contact us
    • They support us
  • The stakes
    • Advances made by research : where are we?
    • Progress of research : the experts speak
    • The path of drug discovery
  • Our research
    • Our scientific orientations : cancer escape and immune surveillance
    • From science to the patient : therapeutic targeting
    • Dedicated teams
  • Platforms and networks
    • The bioinformatics platform
    • Chairs of excellence
    • The C3D
    • The Tumor model laboratory
    • World Sarcoma Network
  • Support the Foundation
    • You are private individual
    • You are a company
    • Glossary
    • News
    • Photo gallery (In French)
    • Videos

Centre Léon Bérard

Direction de la Recherche - Cheney D

28, rue Laënnec 69008 Lyon

+33 674 65 67 02

  • References
  • Acknowledgements
  • Creation by Acti
  • Sitemap
  • Terms and Conditions

All right reserved Synergie Lyon Cancer 2013